Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy
WJ Stafford,
RG Trohman,
M Bilsker,
L Zaman,
A Castellanos,
and
RJ Myerburg
A 15 year old youth, who presented with out-of-hospital cardiac arrest due to documented ventricular fibrillation, was found to have nonobstructive hypertrophic cardiomyopathy. Electrophysiologic study demonstrated inducible sustained atrial fibrillation with a rapid ventricular response. This rhythm, associated with hypotension and evidence of myocardial ischemia, spontaneously degenerated into ventricular fibrillation. No ventricular arrhythmias were inducible by programmed ventricular stimulation. Therapy with metoprolol and verapamil slowed the ventricular rate during atrial fibrillation and maintained hemodynamic stability, both during follow-up electrophysiologic study and during a subsequent spontaneous episode.
This article has been cited by other articles:

|
 |

|
 |
 
P. Vassallo and R. G. Trohman
Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications
JAMA,
September 19, 2007;
298(11):
1312 - 1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1687 - 1713.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J.,
November 1, 2003;
24(21):
1965 - 1991.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P. G. Camici
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
N. Engl. J. Med.,
September 11, 2003;
349(11):
1027 - 1035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maron
Hypertrophic Cardiomyopathy: A Systematic Review
JAMA,
March 13, 2002;
287(10):
1308 - 1320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Olivotto, F. Cecchi, S. A. Casey, A. Dolara, J. H. Traverse, and B. J. Maron
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Circulation,
November 20, 2001;
104(21):
2517 - 2524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J.,
August 2, 2001;
22(16):
1374 - 1450.
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Gil, F. Arribas, and F. G. Cosio
Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy
Europace,
January 1, 2000;
2(4):
327 - 332.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Elliott, S. Sharma, A. Varnava, J. Poloniecki, E. Rowland, and W. J. McKenna
Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1596 - 1601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K PRASAD and M P FRENNEAUX
Sudden death in hypertrophic cardiomyopathy: potential importance of altered autonomic control of vasculature
Heart,
June 1, 1998;
79(6):
538 - 540.
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Lazzeroni, E. Picano, L. Morozzi, A. R. Maurizio, G. Palma, R. Ceriati, E. Iori, and A. Barilli
Dipyridamole-Induced Ischemia as a Prognostic Marker of Future Adverse Cardiac Events in Adult Patients With Hypertrophic Cardiomyopathy
Circulation,
December 16, 1997;
96(12):
4268 - 4272.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Sadoul, K. Prasad, P. M. Elliott, S. Bannerjee, M. P. Frenneaux, and W. J. McKenna
Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy
Circulation,
November 4, 1997;
96(9):
2987 - 2991.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. E. Josephson
Antiarrhythmic Agents and the Danger of Proarrhythmic Events
Ann Intern Med,
July 15, 1989;
111(2):
101 - 103.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Falk
Flecainide-Induced Ventricular Tachycardia and Fibrillation in Patients Treated for Atrial Fibrillation
Ann Intern Med,
July 15, 1989;
111(2):
107 - 111.
[Abstract]
[PDF]
|
 |
|
|